Mark J. Ratain
Observed names: M Ark J. Ratain, M J Ratain, M RATAIN, M Ratain, M. J. RATAIN, M. J. Ratain, M. Ratain, M.J Ratain, M.J. Ratain, MARK J. RATAIN, MJ RATAIN, MJ Ratain, Mark J Ratain, Mark J. Ratain Md, Mark Ratain, MarkJ. Ratain, Ratain Mark, Ratain Mark J, Ratain,, Ratain, Mark J.
Institutions: University of Chicago, University of Chicago Medical Center
Observed institutions: Rutgers, The State University of New Jersey, Dartmouth College, Northwestern University, University of North Carolina at Chapel Hill, University of Southern California, Universitat Autònoma de Barcelona, Uppsala University, University of Iowa, University of Maryland, Baltimore, Brigham and Women's Hospital, Rush University Medical Center, Dartmouth–Hitchcock Medical Center, Fox Chase Cancer Center, BC Cancer Agency, Roswell Park Comprehensive Cancer Center, SRI International, National Institutes of Health, City Of Hope National Medical Center, Mission Health, St. Jude Children's Research Hospital, United States Food and Drug Administration, The Royal Melbourne Hospital, Regenstrief Institute, Mayo Clinic, Center for Drug Evaluation and Research, Memorial Sloan Kettering Cancer Center, Endeavor Health, The University of Texas MD Anderson Cancer Center, Harvard University, Institute of Cancer Research, Johns Hopkins University, Uniformed Services University of the Health Sciences, Exelixis (United States), University of California, Los Angeles, Merck KGaA, Darmstadt (Germany), The University of Melbourne, Eli Lilly (United States), University of Pittsburgh, Duke University, German Cancer Research Center, University of California, San Francisco, Pfizer (United States), Illinois Institute of Technology, Shanghai Jiao Tong University, Genentech, Georgetown University, Ludwig Cancer Research, Vanderbilt University, University of Washington, University of California, Irvine, QIMR Berghofer Medical Research Institute, University of Utah, University of Michigan, Alliance for Clinical Trials in Oncology, Johns Hopkins Medicine, Georgetown University Medical Center, Walter Reed National Military Medical Center, Rabin Medical Center, North Shore University Hospital, Peter MacCallum Cancer Centre, Seoul National University Hospital, The Ohio State University Wexner Medical Center, Moffitt Cancer Center, Arroyo Grande Community Hospital, Yale University, University of Florida, University of California San Diego, University of Illinois Chicago, University of Oxford, University of Chicago, NYU Langone Health, University of Chicago Medical Center, Massachusetts General Hospital, The Royal Victorian Eye & Ear Hospital, Bristol-Myers Squibb (United States), National Institute of Environmental Health Sciences, University of Wisconsin Carbone Cancer Center, Centre for Eye Research Australia, City of Hope, RIKEN, Melanoma Research Alliance, GlaxoSmithKline (United States), Michigan Medicine, VA Center for Clinical Management Research, Emmes (United States), Universitätsmedizin Göttingen, Dana-Farber Cancer Institute, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Taiho Pharmaceutical (Japan), Royal Marsden Hospital, Ludwig Cancer Research, Duke Medical Center, Cancer Research Center, Vall d'Hebron Hospital Universitari, UPMC Hillman Cancer Center, University of Kansas Medical Center, Corcept Therapeutics (United States), University of Colorado Cancer Center, Stanford Medicine, National Cancer Institute, AstraZeneca (Sweden), Duke University Health System, National Institutes of Health Clinical Center, Synta Pharmaceuticals (United States), Sidney Kimmel Comprehensive Cancer Center, Japanese Foundation For Cancer Research, Vall d'Hebron Institute of Oncology, ARIAD Pharmaceuticals (United States), Indiana University Indianapolis, University of Chicago Medicine Comprehensive Cancer Center, U-M Rogel Cancer Center, Abramson Cancer Center, Winship Cancer Institute, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Rutgers Cancer Institute, UNC Lineberger Comprehensive Cancer Center, Indiana University School of Medicine, Canadian Cancer Trials Group, University College London, Wake Forest University, Rush University, McGill University, The Ohio State University, New York University, Indiana University, University of Göttingen, The University of Tokyo, Columbia University, University of Pennsylvania, University of California, Davis, Science Applications International Corporation (United States), National Cheng Kung University, The University of Texas Health Science Center at Houston, University of Edinburgh
ORCID: 0000-0002-0938-4392
Observed ORCID: 0000-0002-0938-4392
OpenAlex ID: A5068268371